Skip to content

Short Duration Versus Fourteen Days Antibiotic in Common Bile Duct Cholangitis

An Open-labeled, Randomized Controlled Trial Comparing Between Short Duration And Standard Fourteen Days Antibiotic Treatments In Patients With Acute Common Bile Duct Stone Cholangitis After Successful Endoscopic Biliary Drainage

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03422042
Enrollment
36
Registered
2018-02-05
Start date
2017-08-13
Completion date
2019-08-30
Last updated
2020-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Cholangitis, Common Bile Duct Calculi

Brief summary

Common bile duct stone cholangitis is a potentially fatal condition, characterized by an obstruction and bacterial infection of biliary system. The principles of management are appropriate biliary drainage and systemic antibiotics. There has been limited data about appropriate time of antibiotics in patient with successful endoscopic drainage.

Detailed description

The aim is comparing the efficacy and safety between short duration and standard fourteen days antibiotic treatment in patients with acute common bile duct stone (CBDS) cholangitis after successful endoscopic biliary drainage as regards recurrence rate of acute cholangitis, complete stone clearance rate, morbidity and mortality associated acute cholangitis, and complications related ERCP procedure. The study will be divided patients with acute CBDS cholangitis with complete stone clearance into 2 groups, group (A) will be received intravenous antibiotic until the temperature is less than 37.8 c for 72 hours and group (B) will be received intravenous antibiotic for 7 days, followed by oral antibiotic for 7 days, regardless of the body temperature.

Interventions

OTHERShort duration of antibiotic

Patient will received intravenous antibiotic until the body temperature is less than 37.8 c fir 72, then antibiotic is discontinued.

OTHERStandard treatment of antibiotic

Patient will received intravenous antibiotic for 7 days, followed by oral antibiotic for 7 days, regardless of the body temperature.

Sponsors

Prince of Songkla University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age ≥ 18 years old * diagnosis of acute mild to moderate severity of ascending common bile duct stone cholangitis * endoscopic retrograde cholangiopancreatography (ERCP) with biliary drainage within 72 hours after admission

Exclusion criteria

* pregnant woman * the cause of obstruction other than common bile duct stone * severe co-morbid diseases such as cardiovascular/pulmonary/kidney disease * active concomitant infections of other organs * history of allergy to cephalosporin group

Design outcomes

Primary

MeasureTime frameDescription
The recurrence rate of cholangitis8 weeksThe number of patients who has recurrence of fever after complete treatment without other sources identified

Secondary

MeasureTime frameDescription
The rate of adequacy of drainage24 hoursThe number of patient with cholangiography at the end of the procedure showed no fill defect in the bile duct.
Complication rate4 weeksThe number of patients who developed complications related procedure included pancreatitis, bleeding, perforation, cholangitis as defined and graded according to the consensus guideline and sedation related complications.
Mortality rate4 weeksThe number of patient with death

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026